Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Beelen, MD
Myrexis Inc.
Study Director - Lawrence Recht, MD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Barrow Neurological Institute
Phoenix, Arizona, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Stanford University
Stanford, California, United States
- Northwestern University
Chicago, Illinois, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Lahey Clinic
Burlington, Massachusetts, United States
- University of Massachusettes
Worcester, Massachusetts, United States
- Darthmouth -Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Columbia University
New York, New York, United States
- Scca/university of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2009
- Primary completion
- 31 Jul 2011
- Completion
- 30 Sept 2011
- Last update posted
- 14 Oct 2011
- Registered enrollment
- 56
- Registry id
- NCT00892931
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.